Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases

J Cutan Pathol. 2012 Jan;39(1):33-9. doi: 10.1111/j.1600-0560.2011.01808.x. Epub 2011 Nov 3.

Abstract

Amelanotic melanoma can have a varied appearance both clinically and microscopically. Here, we present our experiences with 75 cases of amelanotic melanoma defined clinically as a non-pigmented lesion and histopathologically as a tumor lacking significant melanization. We evaluated microscopic features such as morphology, mitotic count, nuclear atypia and presence of solar elastosis. Our amelanotic melanomas exhibited the following morphology: epitheloid (72%), spindled (18.7%) or desmoplastic (5.3%). In addition, we obtained patient information and clinical presentations on most of the cases (74/75; 98.7%) and follow-up data on 40% (30/75) of the cases. The majority of amelanotic melanomas in men were found on the trunk (13/45; 29%), head and neck (12/45; 26.7%), and lower limb (13/45; 29%) and in women were found on the lower limb (12/30; 40%), upper limb (10/30; 33.3%) and head and neck (6/30; 20%). In addition, we found that an increase in mitotic index correlated with worse survival (p < 0.026), whereas there were no differences in survival for other pathological features, such as nuclear atypia or solar elastosis. Furthermore, in cases with available tissue, all amelanotic melanoma expressed microphthalmia-associated transcription factor and tyrosinase, suggesting that the tumor cells retained melanocytic lineage and an enzyme in melanin formation, respectively. As the occurrence of amelanotic melanoma and the expression melanoma markers were similar to pigmented melanoma, we favor that amelanotic melanoma represents a subtype of melanoma rather than poorly differentiated or de-differentiated melanoma.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / biosynthesis*
  • Cell Nucleus / metabolism
  • Cell Nucleus / pathology
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic*
  • Head and Neck Neoplasms* / metabolism
  • Head and Neck Neoplasms* / mortality
  • Head and Neck Neoplasms* / pathology
  • Humans
  • Male
  • Melanins / metabolism
  • Melanoma, Amelanotic* / metabolism
  • Melanoma, Amelanotic* / mortality
  • Melanoma, Amelanotic* / pathology
  • Middle Aged
  • Mitosis
  • Retrospective Studies
  • Sex Factors
  • Skin Neoplasms* / metabolism
  • Skin Neoplasms* / mortality
  • Skin Neoplasms* / pathology
  • Survival Rate

Substances

  • Biomarkers, Tumor
  • Melanins